Projects per year
Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Division of Surgical Oncology, Melanoma & Soft Tissue Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Melanoma
Medicine & Life Sciences
Riluzole
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Hispanic Americans
Medicine & Life Sciences
Melanocytes
Medicine & Life Sciences
Skin Neoplasms
Medicine & Life Sciences
Solar System
Medicine & Life Sciences
Glutamic Acid
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2010 2017
- 3 Finished
Regulation of tumor released exosomes and glutamatergic signaling
12/17/14 → 11/30/17
Project: Research project
Exosomes
Melanoma
Neoplasms
Riluzole
Neoplasm Metastasis
A Patient Oriented Research Program For Surgical Oncologists
Goydos, J.
National Institutes of Health (NIH)
7/5/10 → 6/30/15
Project: Research project
Melanoma
Riluzole
Translational Medical Research
Research
Medical Laboratory Science
Combination Therapy That Targets Glutamate Signaling In Melanoma
Goydos, J.
National Institutes of Health (NIH)
4/22/10 → 1/31/15
Project: Research project
Glutamic Acid
Melanoma
Riluzole
Therapeutics
Carcinogenesis
Research Output 2001 2018
2
Citations
(Scopus)
Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo
Chen, S., Jan 1 2018, In : Oncotarget. 9, 5, p. 5861-5875 15 p.Research output: Contribution to journal › Article
Melanocytes
Melanoma
Penetrance
Cell Aging
Nevus
5
Citations
(Scopus)
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
Mehnert, J. M., Silk, A. W., Kane, M., Shih, W. J. & Chen, S., Jul 2018, In : Pigment Cell and Melanoma Research. 31, 4, p. 534-540 7 p.Research output: Contribution to journal › Article
Riluzole
Tumors
Melanoma
Pharmacokinetics
Down-Regulation
4
Citations
(Scopus)
Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness
Chen, S., Jan 1 2018, In : Oncotarget. 9, 1, p. 1187-1199 13 p.Research output: Contribution to journal › Article
Exosomes
Cell Movement
Melanoma
Cellular Microenvironment
Neoplasms
Press/Media
Rutgers prof suspended after assault rifle found in home
James Goydos
5/4/18
1 item of Media coverage
Press/Media: Press / Media
RUTGERS ALUMNUS PENS BOOK TO GUIDE CANCER PATIENTS AND CAREGIVERS
Bruce Haffty & James Goydos
12/21/17
1 item of Media coverage
Press/Media: Press / Media
Rutgers Alumnus Pens Book to Guide Cancer Patients and Caregivers
Bruce Haffty & James Goydos
12/20/17
1 item of Media coverage
Press/Media: Press / Media